Risk factors for lung disease progression in children with cystic fibrosis
- PMID: 30287494
- DOI: 10.1183/13993003.01492-2018
Risk factors for lung disease progression in children with cystic fibrosis
Conflict of interest statement
Conflict of interest: H. Al Momani has nothing to disclose. Conflict of interest: A. Perry has nothing to disclose. Conflict of interest: R. Jones has nothing to disclose. Conflict of interest: M. McDonnell has nothing to disclose. Conflict of interest: A. Krishnan has nothing to disclose. Conflict of interest: A. Robertson has nothing to disclose. Conflict of interest: M. Griffin has nothing to disclose. Conflict of interest: R. Rutherford has nothing to disclose. Conflict of interest: M. Brodlie reports grants from Pfizer and Roche Diagnostics, honoraria for talking at educational meetings (paid to Newcastle University) from Novartis, honoraria and travel expenses for talking at educational meetings (paid to Newcastle University) from TEVA and Roche Diagnostics, and travel expenses to attend educational meetings from Boehringer Ingelheim, outside the submitted work. Conflict of interest: J. Pearson has nothing to disclose. Conflict of interest: S. Bourke has nothing to disclose. Conflict of interest: C. Ward has nothing to disclose.
Comment on
-
Risk factors for lung disease progression in children with cystic fibrosis.Eur Respir J. 2018 Jun 7;51(6):1702509. doi: 10.1183/13993003.02509-2017. Print 2018 Jun. Eur Respir J. 2018. PMID: 29773689